IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Octagon Capital Advisors LP

Q4 2025 Holdings

Filed 2026-02-17 | 27 holdings | $823.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abivax SA(ABVX)SPONSORED ADS00370M103$102.0M756,00012.4%
Dianthus Therapeutics Inc(DNTH)COM252828108$99.6M2,416,66712.1%
Cogent Biosciences Inc(COGT)COM19240Q201$83.5M2,350,00010.1%
Taysha Gene Therapies Inc(TSHA)COM SHS877619106$48.7M8,859,9115.9%
Gossamer BIO Inc(GOSS)COM38341P102$43.1M13,915,3715.2%
Kymera Therapeutics Inc(KYMR)COM501575104$41.6M535,0005.1%
Arrivent Biopharma Inc(AVBP)COM04272N102$39.7M1,971,0544.8%
Trevi Therapeutics Inc(TRVI)COM89532M101$35.2M2,815,0004.3%
Ocular Therapeutix Inc(OCUL)COM67576A100$31.9M2,623,6003.9%
Mind Medicine Mindmed Inc(BRD1EUR)COM NEW60255C885$29.9M2,230,0003.6%
CG Oncology Inc(CGON)CallCOM156944100$24.9M600,0003.0%
Alumis Inc(ALMS)COM022307102$24.7M2,530,7003.0%
Palisade BIO Inc(PALI)COM696389402$22.5M9,567,8982.7%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$22.1M100,0002.7%
Bioage Labs Inc(BIOA)COM09077V100$21.1M1,598,0002.6%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$20.6M1,273,3332.5%
Rapt Therapeutics Inc(RAPT)COM NEW75382E208$19.4M574,0002.4%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$18.8M750,0002.3%
Pharvaris N V(PHVS)COMN69605108$18.6M671,4652.3%
Lexeo Therapeutics Inc(LXEO)COM52886X107$17.1M1,725,0002.1%
Bridgebio Oncology Therapeut(BBOT)COM NEW107924102$13.1M1,043,1101.6%
DBV Technologies S A(DBVT)SPONSORED ADS23306J309$11.0M574,2001.3%
Evommune Inc(EVMN)COM SHS30054Y107$8.6M500,0001.0%
Precision Biosciences Inc(DTIL)COM NEW74019P207$8.0M1,917,9951.0%
Corbus Pharmaceuticals Hldgs(CRBP)COM NEW21833P301$7.8M955,0000.9%
Unicycive Therapeutics Inc(UNCY)COM NEW90466Y202$5.8M1,000,0000.7%
Pepgen Inc(PEPG)COM713317105$4.6M700,0000.6%